Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CC | DD |
|---|---|---|
| Price | $13.89 | $130.69 |
| Change today | ▲ 1.31% | ▲ 0.55% |
| Market cap | $2.09B | $17.65B |
| Return, 3 months | -25.9% | -5.7% |
| Return, year to date | +19.5% | +10.0% |
| Return, 1 year | -10.2% | +30.3% |
| P/E (TTM) | -6.9 | 326.7 |
| P/B | -42.6 | 1.3 |
| P/E percentile vs own 5y | 32nd | 98th |
| Dividend yield | 2.52% | 2.32% |
| Revenue growth (YoY, latest qtr) | -1.5% | +4.0% |
| Net profit growth (YoY) | +27.7% | +110.0% |
| Gross margin | 18.0% | 35.1% |
| Operating margin | -13.2% | 13.6% |
| Net margin | -17.2% | 0.8% |
| Return on equity | – | 0.3% |
| Analyst target vs. price | +34.7% | +29.0% |
| Analyst buy share | 63% | 75% |
| RSI (14) | 40 | 48 |
| 30-day volatility | 31.6% | 18.6% |
| Max drawdown, 1 year | -51.3% | -18.4% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
